WallStSmart

Alignment Healthcare LLC (ALHC)vsHumana Inc (HUM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Humana Inc generates 3123% more annual revenue ($137.20B vs $4.26B). ALHC leads profitability with a 0.5% profit margin vs 0.0%. HUM trades at a lower P/E of 41.5x. HUM earns a higher WallStSmart Score of 52/100 (C-).

ALHC

Hold

45

out of 100

Grade: D+

Growth: 8.0Profit: 4.5Value: 4.3Quality: 6.0
Piotroski: 4/9Altman Z: 2.95

HUM

Buy

52

out of 100

Grade: C-

Growth: 4.7Profit: 4.0Value: 4.7Quality: 6.5
Piotroski: 4/9Altman Z: 3.91
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ALHCUndervalued (+4.6%)

Margin of Safety

+4.6%

Fair Value

$21.37

Current Price

$18.29

$3.08 discount

UndervaluedFair: $21.37Overvalued
HUMUndervalued (+0.6%)

Margin of Safety

+0.6%

Fair Value

$402.40

Current Price

$365.41

$36.99 discount

UndervaluedFair: $402.40Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ALHC1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
33.3%10/10

Revenue surging 33.3% year-over-year

HUM3 strengths · Avg: 8.7/10
Altman Z-ScoreHealth
3.9110/10

Safe zone — low bankruptcy risk

Price/BookValuation
2.4x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$1.13B8/10

Generating 1.1B in free cash flow

Areas to Watch

ALHC4 concerns · Avg: 3.5/10
Price/BookValuation
18.3x4/10

Trading at 18.3x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Profit MarginProfitability
0.5%3/10

0.5% margin — thin

Operating MarginProfitability
1.3%3/10

Operating margin of 1.3%

HUM4 concerns · Avg: 3.5/10
PEG RatioValuation
2.244/10

Expensive relative to growth rate

Revenue GrowthGrowth
0.2%4/10

0.2% revenue growth

Return on EquityProfitability
6.1%3/10

ROE of 6.1% — below average capital efficiency

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : ALHC

The strongest argument for ALHC centers on Revenue Growth. Revenue growth of 33.3% demonstrates continued momentum.

Bull Case : HUM

The strongest argument for HUM centers on Altman Z-Score, Price/Book, Free Cash Flow.

Bear Case : ALHC

The primary concerns for ALHC are Price/Book, EPS Growth, Profit Margin. A P/E of 206.0x leaves little room for execution misses. Debt-to-equity of 1.59 is elevated, increasing financial risk.

Bear Case : HUM

The primary concerns for HUM are PEG Ratio, Revenue Growth, Return on Equity. A P/E of 41.5x leaves little room for execution misses. Thin 0.0% margins leave little buffer for downturns.

Key Dynamics to Monitor

ALHC profiles as a hypergrowth stock while HUM is a value play — different risk/reward profiles.

ALHC carries more volatility with a beta of 1.05 — expect wider price swings.

ALHC is growing revenue faster at 33.3% — sustainability is the question.

HUM generates stronger free cash flow (1.1B), providing more financial flexibility.

Bottom Line

HUM scores higher overall (52/100 vs 45/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Alignment Healthcare LLC

HEALTHCARE · HEALTHCARE PLANS · USA

Alignment Healthcare, Inc. provides a consumer-centric platform that provides personalized healthcare to seniors in the United States. The company is headquartered in Orange, California.

Humana Inc

HEALTHCARE · HEALTHCARE PLANS · USA

Humana Inc. is a for-profit American health insurance company based in Louisville, Kentucky.

Visit Website →

Want to dig deeper into these stocks?